Author:
Mieritz Mikkel G,Christiansen Peter,Jensen Martin Blomberg,Joensen Ulla N,Nordkap Loa,Olesen Inge A,Bang A Kirstine,Juul Anders,Jørgensen Niels
Abstract
Objective
Gynaecomastia is a benign proliferation of glandular tissue of the breast; however, it is an important clinical observation because it can be the first symptom of an underlying disease. Some controversy exists concerning the clinical importance of an in-depth investigation of men who develop gynaecomastia. We hypothesise that a thorough work-up is required in adult men with gynaecomastia.
Design
All adult men (n = 818) referred to a secondary level andrological department at Rigshospitalet in Copenhagen, Denmark during a four-year period (2008–2011) under the diagnosis of gynaecomastia (ICD-10: N62) were included.
Methods
Thirty-two men who did not have gynaecomastia when examined were excluded; leaving 786 men for final analyses. They underwent an andrological examination, ultrasound of the testicles and analysis of endogenous serum hormones levels.
Results
In 43% of men with adult onset of gynaecomastia (≥18 years) an underlying, and often treatable, cause could be detected. In men younger at onset an underlying cause for gynaecomastia could be detected in merely 7.7%. The study is limited by the fact that we did not have access to investigate men who were referred directly by their GP to private clinics for plastic surgery or who sought cosmetic correction without consulting their GP first.
Conclusions
Our study demonstrates the importance of a thorough examination and provides a comprehensible examination strategy to disclose the underlying pathology leading to the development of gynaecomastia in adulthood.
Subject
Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Borstzwelling bij mannen/gynaecomastie;Kleine Kwalen in de huisartsenpraktijk;2023-11-14
2. Gynecomastia;Andrology;2023
3. Gynäkomastie;Andrologie;2023
4. Management;A Guide to Management of Urological Cancers;2023
5. Management of Gynecomastia and Male Benign Diseases;Surgical Clinics of North America;2022-12